Bionano Genomics, Inc. financial data

Symbol
BNGO on Nasdaq
Location
9540 Towne Centre Drive, Suite 100, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
BioNanomatrix Inc (to 3/24/2011)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 146 % -59.1%
Quick Ratio 39.7 % -54.5%
Debt-to-equity 91.2 % +212%
Return On Equity -176 % -57.9%
Return On Assets -92.2 % -6.78%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 102M shares +163%
Common Stock, Shares, Outstanding 88.5M shares +150%
Entity Public Float 201M USD -49.7%
Common Stock, Value, Issued 9K USD +200%
Weighted Average Number of Shares Outstanding, Basic 85.9M shares +145%
Weighted Average Number of Shares Outstanding, Diluted 85.9M shares +145%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 33.3M USD -0.82%
Research and Development Expense 33M USD -41.4%
Costs and Expenses 116M USD -50.8%
Operating Income (Loss) -117M USD +48.6%
Nonoperating Income (Expense) -18.8M USD -869%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -136M USD +39.8%
Income Tax Expense (Benefit) -4K USD -100%
Net Income (Loss) Attributable to Parent -136M USD +40.3%
Earnings Per Share, Basic -2.48 USD/shares +68.7%
Earnings Per Share, Diluted -2.48 USD/shares +68.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.79M USD -74.6%
Accounts Receivable, after Allowance for Credit Loss, Current 5.32M USD -38.7%
Inventory, Net 16.3M USD -51.4%
Other Assets, Current 976K USD -59.5%
Assets, Current 47M USD -55.1%
Property, Plant and Equipment, Net 20M USD -5.98%
Operating Lease, Right-of-Use Asset 2.83M USD -54.1%
Intangible Assets, Net (Excluding Goodwill) 11M USD -69.1%
Goodwill 0 USD -100%
Other Assets, Noncurrent 2.76M USD -73%
Assets 87.4M USD -52%
Accounts Payable, Current 8.7M USD -43.4%
Employee-related Liabilities, Current 4.01M USD -52.9%
Accrued Liabilities, Current 5.88M USD -49.1%
Contract with Customer, Liability, Current 1.2M USD +47.3%
Liabilities, Current 33M USD -18%
Contract with Customer, Liability, Noncurrent 263K USD +74.2%
Operating Lease, Liability, Noncurrent 1.73M USD -57.7%
Liabilities 38.5M USD -38.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.53M USD
Retained Earnings (Accumulated Deficit) -673M USD -25.3%
Stockholders' Equity Attributable to Parent 48.9M USD -58.9%
Liabilities and Equity 87.4M USD -52%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.1M USD +13.2%
Net Cash Provided by (Used in) Financing Activities -21.6M USD -245%
Net Cash Provided by (Used in) Investing Activities 47.6M USD +188%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 88.5M shares +150%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.19M USD -122%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.19M USD -73.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.62M USD +7295%
Deferred Tax Assets, Valuation Allowance 111M USD -9.26%
Deferred Tax Assets, Gross 120M USD -10%
Operating Lease, Liability 3.69M USD -41.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -134M USD +40.5%
Lessee, Operating Lease, Liability, to be Paid 4.04M USD -43.2%
Property, Plant and Equipment, Gross 42.4M USD +36.4%
Operating Lease, Liability, Current 1.96M USD -10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 545K USD -80.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.61M USD -2.83%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 349K USD -58.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 254K USD -65.2%
Deferred Tax Assets, Operating Loss Carryforwards 92M USD -16.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.99M USD -31.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD -100%
Operating Lease, Payments 669K USD +3.88%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3.01M USD -5.74%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 11.2M USD -35.4%
Interest Expense 5.17M USD +1639%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%